| |
| |
|
| Insider
Information: |
Kuriyel Ralf |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
24,260 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,841,814 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
24,260 |
|
|
| Total
Value |
$3,841,814 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.7
|
| Percentage
Gain/Loss : |
0.0%
|
 591.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Repligen Corp |
RGEN |
|
2024-03-11 |
24,260 |
2018-03-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-03-11 |
4 |
S |
$193.73 |
$681,348 |
D/D |
(3,517) |
24,260 |
0 |
% |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-03-11 |
4 |
OE |
$86.10 |
$109,433 |
D/D |
1,271 |
27,777 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-03-07 |
4 |
D |
$195.72 |
$75,548 |
D/D |
(386) |
26,506 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-03-04 |
4 |
D |
$193.99 |
$26,189 |
D/D |
(135) |
26,892 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-03-01 |
4 |
D |
$191.79 |
$86,881 |
D/D |
(453) |
27,027 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
404 |
27,480 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,520 |
27,076 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2023-05-16 |
4 |
D |
$154.03 |
$109,361 |
D/D |
(710) |
23,556 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2023-03-03 |
4 |
D |
$188.00 |
$234,436 |
D/D |
(1,247) |
24,266 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,591 |
25,513 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,468 |
21,922 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2023-02-28 |
4 |
D |
$173.44 |
$79,436 |
D/D |
(458) |
18,812 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2023-02-28 |
4 |
D |
$173.28 |
$62,034 |
D/D |
(358) |
18,454 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-08-11 |
4 |
S |
$254.14 |
$1,230,886 |
D/D |
(4,840) |
19,270 |
0 |
% |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-08-11 |
4 |
OE |
$33.05 |
$202,311 |
D/D |
4,000 |
24,110 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-05-13 |
4 |
D |
$150.40 |
$107,085 |
D/D |
(712) |
20,110 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-28 |
4 |
D |
$196.70 |
$404,612 |
D/D |
(2,057) |
20,822 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,234 |
22,406 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-27 |
4 |
D |
$196.70 |
$93,826 |
D/D |
(477) |
18,645 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-24 |
4 |
D |
$189.21 |
$35,571 |
D/D |
(188) |
19,122 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,126 |
19,310 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-17 |
4 |
D |
$182.42 |
$31,924 |
D/D |
(175) |
17,184 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
450 |
17,359 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2021-12-14 |
4 |
D |
$252.53 |
$112,376 |
D/D |
(445) |
16,909 |
0 |
- |
|
| RGEN |
Repligen Corp |
Senior VP, R&D |
• – – |
2021-08-30 |
4 |
S |
$282.13 |
$1,128,802 |
D/D |
(4,001) |
17,354 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
